U.S. House Oversight Committee Sends Letter to Mylan (MYL) CEO Bresch; Requests EpiPen Info
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
The U.S. House Committee on Oversight and Government Reform sent a letter to Mylan (NASDAQ: MYL) CEO Heather Bresch today. In part, the letter requests a briefing on EpiPen, as well as certain supporting documents and information.
The letter from Reps Jason Chaffetz and Elijah Cummings is embedded below:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mylan (MYL) Announces U.S. Launch of Generic Benicar Tabs
- Notable Analyst Rating Changes 10/26: (AKAM) (AKS) (GXP) Upgraded; (GM) (DPRX) (SPN) Downgraded
- Randstad Reports EC Approval For Acquisition of Monster Worldwide (MWW)
Create E-mail Alert Related CategoriesCorporate News, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!